Category: Pharma News
Pharmacopoeia standards for medications used in Ayurveda, Siddha, Unani, and homoeopathy will shortly be developed by PCIM&H.
The Pharmacopoeia Commission of Indian Medicine and Homoeopathy (PCIM&H) may soon start developing pharmacopoeia standards for the Ayurvedic,…
Cabaletta Bio’s IND application for CABA-201 to treat systemic lupus erythematosus has been approved by the US FDA.
The US Food and Drug Administration has approved the company’s investigational new drug (IND) application for CABA-201, a…
Apply for the position of JRF under ICMR at Birla Institute of Technology & Science Pilani
Applications are invited from suitable candidates for a Junior Research Fellow (JRF) position to work on the following…
Imlifidase phase 2 study enrolment by Hansa Biopharma for patients with Guillain-Barré syndrome is already complete.
The phase 2 recruitment for Hansa Biopharma’s imlifidase research in Guillain-Barré syndrome has been completed, according to the…
A committee of specialists is assembled by the Health Ministry to examine the Pharmacy Act and restructure PCI.
The Pharmacy Council of India (PCI), a statutory body established for the regulation of pharmacy education, profession, and…
The Delhi High Court rejects Boehringer Ingelheim’s request for a temporary restraining order, and generic linagliptin production is permitted.
In a patent dispute involving the former’s diabetes drug linagliptin, a single judge of the Delhi High Court…
The current rate of HIV transmission through blood transfusion is less than 1%, compared to the past, when it was 15%: NACO
According to the National AIDS Control Organization, the risk of HIV transmission through blood transfusions has decreased from…
The FDA has fully approved Keytruda, a Merck anti-PD-1 medication, for use in a small number of adult and paediatric patients with advanced MSI-H or mismatch repair deficient solid tumours.
The US Food and Drug Administration (FDA) has fully approved Keytruda, Merck’s anti-PD-1 therapy, for the treatment of…
Abbott’s Epic Max tissue valve is approved by the US FDA to treat aortic valve disease.
In order to treat persons with aortic regurgitation or stenosis, Abbott announced that the US Food and Drug…
The OTC naloxone nasal spray from Emergent BioSolutions has received FDA approval.
The first naloxone medication to be approved for use without a prescription is Narcan, a 4 milligramme (mg)…
